Eagle’s Eye View: ACC/AHA Joint Perioperative Guidelines; Atenolol and MACE Risk; Yoga and VPCs; DECIPHER & CMR
In this week’s View, Dr. Eagle looks at how the most recent perioperative guideline published in 2024 remains valid and current. He then examines how, in the treatment of patients without recorded heart failure (HF), starting atenolol after a myocardial infarction (MI) was associated with a lower two-year risk of major adverse cardiovascular events (MACE), but not all-cause mortality. He follows that with a look at patients with frequent ventricular premature complexes (VPCs) and how a structured yoga program compared with standard care reduced VPCs as well as improved quality of life (QOL) and psychological burden. Finally, Dr. Eagle discusses the DECIPHER HFpEF Study on cardiac magnetic resonance (CMR) tissue mapping and its capture of active relaxation impairment (σ) and passive stiffness (β) in invasively characterized heart failure with preserved ejection fraction (HFpEF).
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Prevention, Anticoagulation Management and Atrial Fibrillation, EP Basic Science, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Acute Heart Failure, Exercise, Acute Coronary Syndromes
Keywords: EaglesEyeView, Perioperative Care, Atrial Fibrillation, Sodium-Glucose Transporter 2 Inhibitors, Anticoagulants, Bisoprolol, Atenolol, Myocardial Infarction, Mortality, Ventricular Premature Complexes, Quality of Life, Yoga, Exercise, Magnetic Resonance Spectroscopy, Ventricular Dysfunction, Left, Heart Failure, Heart Failure, Preserved Ejection Fraction
